Log in to save to my catalogue

Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis

Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d4f06b1607cd407a9add5c0e87c114fd

Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis

About this item

Full title

Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis

Publisher

England: British Thoracic Society

Journal title

BMJ open respiratory research, 2023-12, Vol.10 (1), p.e001763

Language

English

Formats

Publication information

Publisher

England: British Thoracic Society

More information

Scope and Contents

Contents

BackgroundIdiopathic pleuroparenchymal fibroelastosis (iPPFE), a progressive fibrotic disease, is characterised by upper lobe–dominant lung fibrosis involving the pleura and subpleural lung parenchyma. However, no prognostic markers have been established for this condition. Associations between blood leucocyte levels and mortality have been reporte...

Alternative Titles

Full title

Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d4f06b1607cd407a9add5c0e87c114fd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d4f06b1607cd407a9add5c0e87c114fd

Other Identifiers

ISSN

2052-4439

E-ISSN

2052-4439

DOI

10.1136/bmjresp-2023-001763

How to access this item